TVM Capital Healthcare's Tristan de Boysson has been appointed as Chairman of neurocare group's Supervisory Board. The Munich-headquartered company is a leading innovator in personalized #mentalhealthcare. Tristan brings decades of experience in #healthcare investing, strategy, and operations. We are a proud investor in #mentalhealth solutions and proud to support neurocare group's international expansion, including in the #US and market entry into #SaudiArabia. Globally, 13.0% of people are affected by #mentaldisorders (according to World Health Organization) and the number of patients diagnosed with mental illnesses doubled during the COVID pandemic. Nevertheless, the treatment of mental health conditions remains significantly lacking in most countries. We look across our markets in the #MiddleEast and #SoutheastAsia for the unique growth opportunities companies like neurocare group offer in innovative treatments with superior clinical outcomes. #Mentalhealth is a core component to our strategy to bring best-in-class healthcare solutions that improve access to quality care.
🚀 Today we make an important announcement. We are very pleased to welcome Tristan de Boysson as Chairman as well as Prof. Dr. Heinrich von Pierer as a Member of the Supervisory Board for neurocare group AG. Mr. de Boysson brings over 25 years of expertise in investing and corporate leadership. He is currently a Managing Partner at TVM Capital Healthcare, a growth capital healthcare-focused private equity firm headquartered in Dubai and Singapore. His previous experience includes serving as the CEO of Amanat Holdings PJSC, the largest listed healthcare and education investment company in the MENA region. Prof. Dr. Heinrich von Pierer brings his considerable global leadership experience and network to neurocare. Beginning his career at Siemens AG in 1969, Prof. Dr. von Pierer advanced to the position of CEO of the global Siemens Group, serving from 1992 to 2005 and leading businesses in engineering, power generation, healthcare, telecommunications, and finance. Subsequently, he served as Siemens’ Chairman of the Supervisory Board. Our Founder & CEO, Tom Mechtersheimer, said, “the neurocare team is grateful to have the expertise of Mr. de Boysson and Prof. Dr. Heinrich von Pierer on our Supervisory Board. Personally, I am much looking forward to driving neurocare with Tristan de Boysson as our Chairman and am humbled to have access to the immense global business and leadership experience of Prof. Dr. von Pierer. This year marks exciting progress in terms of our new global leadership team recently announced, as well as our new supervisory board and funding which will position neurocare as a global leader in mental health.” Complete statements and details can be found in the press release linked here. #neurocare #neurocaregroup #leadership #boardannouncement #corporategovernance #businessgrowth #strategicleadership #businessleadership #executiveleadership https://lnkd.in/eiui4v99
Congratulations Tristan!
Partner I Managing Partner Munich Office l Co-leader of the global private equity practice at Morgan, Lewis & Bockius LLP
2moCongratulations Tristan! Very good choice!